Bridget Morse

Bridget Morse is a highly experienced professional in the field of pharmaceutical sciences, with a robust background in clinical pharmacology. At Eli Lilly and Company from September 2020 to October 2023, Bridget Morse held several prominent roles, including Senior Scientific Director of Quantitative Clinical Pharmacology, Director, and Principal Research Scientist. Previously, Bridget Morse worked as a Research Investigator at Bristol-Myers Squibb from April 2014 to January 2016, and completed a postdoctoral fellowship at Western University in 2013. Bridget Morse earned a PhD in Pharmaceutical Sciences from the University at Buffalo in 2013 and a Doctor of Pharmacy (Pharm.D.) degree from Butler University in 2008.